Iron polymaltose

未找到该活性成分的已注册品牌。

该活性成分暂无已收录的食物注意事项。

• 3-Aza-2,3-Dihydrogeranyl Diphosphate中等

  Iron polymaltose 可能减少 3-Aza-2,3-Dihydrogeranyl Diphosphate 的吸收，从而可能导致血药浓度降低，并可能使疗效减弱。

  专业视图

  Iron polymaltose can cause a decrease in the absorption of 3-Aza-2,3-Dihydrogeranyl Diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.

• Alendronic acid中等

  Iron polymaltose 可能减少 Alendronic acid 的吸收，从而可能导致血药浓度降低，并可能使疗效减弱。

  专业视图

  Iron polymaltose can cause a decrease in the absorption of Alendronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.

• Almasilate中等

  Almasilate 可能减少 Iron polymaltose 的吸收，从而可能导致血药浓度降低，并可能使疗效减弱。

  专业视图

  Almasilate can cause a decrease in the absorption of Iron polymaltose resulting in a reduced serum concentration and potentially a decrease in efficacy.

• Aloglutamol中等

  Aloglutamol 可能减少 Iron polymaltose 的吸收，从而可能导致血药浓度降低，并可能使疗效减弱。

  专业视图

  Aloglutamol can cause a decrease in the absorption of Iron polymaltose resulting in a reduced serum concentration and potentially a decrease in efficacy.

• Aluminium acetoacetate中等

  Aluminium acetoacetate 可能减少 Iron polymaltose 的吸收，从而可能导致血药浓度降低，并可能使疗效减弱。

  专业视图

  Aluminium acetoacetate can cause a decrease in the absorption of Iron polymaltose resulting in a reduced serum concentration and potentially a decrease in efficacy.

• Aluminium glycinate中等

  Aluminium glycinate 可能减少 Iron polymaltose 的吸收，从而可能导致血药浓度降低，并可能使疗效减弱。

  专业视图

  Aluminium glycinate can cause a decrease in the absorption of Iron polymaltose resulting in a reduced serum concentration and potentially a decrease in efficacy.

• Aluminium phosphate中等

  Aluminium phosphate 可能减少 Iron polymaltose 的吸收，从而可能导致血药浓度降低，并可能使疗效减弱。

  专业视图

  Aluminium phosphate can cause a decrease in the absorption of Iron polymaltose resulting in a reduced serum concentration and potentially a decrease in efficacy.

• Aluminum hydroxide中等

  Aluminum hydroxide 可能减少 Iron polymaltose 的吸收，从而可能导致血药浓度降低，并可能使疗效减弱。

  专业视图

  Aluminum hydroxide can cause a decrease in the absorption of Iron polymaltose resulting in a reduced serum concentration and potentially a decrease in efficacy.

• Asenapine中等

  Asenapine 可能减少 Iron polymaltose 的吸收，从而可能导致血药浓度降低，并可能使疗效减弱。

  专业视图

  Asenapine can cause a decrease in the absorption of Iron polymaltose resulting in a reduced serum concentration and potentially a decrease in efficacy.

• Calcium carbonate中等

  Calcium carbonate 可能减少 Iron polymaltose 的吸收，从而可能导致血药浓度降低，并可能使疗效减弱。

  专业视图

  Calcium carbonate can cause a decrease in the absorption of Iron polymaltose resulting in a reduced serum concentration and potentially a decrease in efficacy.